Navigation Links
NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
Date:2/27/2008

Primary and Secondary Endpoints Do Not Achieve Statistical Significance

Company Affirms Plans to File NGX-4010 NDA in 2008

Schedules Investor Conference Call at 5:00 p.m. EST

SAN MATEO, Calif., Feb. 27 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced preliminary top-line results from study C119, its second Phase 3 clinical trial of NGX-4010, the Company's dermal patch drug candidate, in patients with HIV-distal sensory polyneuropathy (HIV-DSP). The prespecified analysis of the primary endpoint, comparing all patients treated with NGX-4010 compared to all patients treated with the control patch, did not meet statistical significance (p=0.1), with the overall NGX-4010 treatment group achieving a 29.5% reduction in pain from baseline over weeks 2 to 12 compared to a 24.6% reduction for the control group. The results were confounded by a much higher than anticipated control group response overall and, in particular, in the 60-minute control arm.

Dr. Jeffrey Tobias, Chief Medical Officer, commented, "We observed responses in the NGX-4010 treatment arms consistent with what we have seen in multiple previous studies. However, the response in the 60-minute control group was greater than anticipated. We are encouraged that the safety profile of this study supports the lack of any observed major safety issues associated with NGX-4010 and that treatment with NGX-4010 was well tolerated. Since these results are preliminary, we have more analysis to carry out on this data. However, our initial evaluation of the data suggests that the NGX-4010 treatment arms behaved similarly to our oth
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
3. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
4. EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
5. Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil
6. MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
7. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
8. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
9. ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
10. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
11. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Haemonetics Corporation (NYSE: ... , CFO & EVP-Business Development, will present at The Deutsche ... Boston, MA on May 29, 2013 ... ) The public may access Mr. Lindop,s ... About Haemonetics Haemonetics (NYSE: HAE ...
(Date:5/23/2013)... , May 23, 2013  TeamHealth Medical ... nurse triage and nurse advice lines, announces its ... comprising physician, nursing and administrative leaders, provides clinical ... quality and cost-effective services for hospital clients, physician ... national healthcare system evolves, it,s imperative to continuously ...
(Date:5/23/2013)... , May 23, 2013  Every day, their baby stopped ... to his lungs. April and Bryan Gionfriddo ... weren,t true. "Quite a few doctors said he ... says April Gionfriddo , about her now ... that would work, we would take it and run with ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4
... Editor ,According to the American Diabetes Association, the ... to be $132 billion, or one out of every 10 ... disease with no cure, diabetes is a group of diseases ... levels of blood glucose resulting from defects in insulin production, ...
... and innovative technology has enabled more and more laboratory ... the central laboratory is hardly threatened with extinction. National ... busier than ever before, and the huge range of ... very large volumes of tests assures them an abiding ...
Cached Medicine Technology:Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control 2Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control 3Immunoassay Systems - Your Laboratory Workhorse 2
(Date:5/25/2013)... 2013 Radius Engineering International Inc., ... in the US and has been building concrete, ... 35 years. M.E. and President, Walton McCarthy, author ... Weapon Fundamentals and Shelter Engineering Standards, Sixth Edition, ... shelter engineering. McCarthy is considered the leading expert ...
(Date:5/25/2013)... New York (PRWEB) May 25, 2013 ... allegedly suffered serious, life-threatening episodes of internal bleeding while using ... underway in U.S. District Court, Southern District of Illinois, Bernstein ... Court’s website, 818 Pradaxa side effect claims had been ... That’s up from 705 claims reported by the Court ...
(Date:5/25/2013)... Many orthodontists have thought about moving their office to ... Most people would naturally assume that the company ... service and support would own and maintain all the ... be wrong. Cloud providers lease space in a ... houses servers and related equipment to run cloud environments) ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 IBISWorld estimates that ... at an average annual rate of 28.7% to $1.0 billion ... in 2013. From 2002 and 2008, no new cell therapy ... causing relatively modest growth during that period. In the years ... six new products. This factor contributed to the industry's fast ...
(Date:5/25/2013)... Superior Magnetics for Pain Free Living announced ... arthritis, tendinitis and bursitis , Pain Free Living - ... a magnetic bracelet so strong it relieves ... is demonstrated at fairs and festivals. This new magnetic ... has customers often report pain relief in seconds. , ...
Breaking Medicine News(10 mins):Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Magnetic bracelet relieves pain in seconds announces Superior Magnetics 2
... rates of cessation, study found, , , WEDNESDAY, Feb. 11 (HealthDay ... them to stop their unhealthy habit helps more people give ... the Feb. 12 issue of the New England Journal ... Co. employees across the country who were offered up to ...
... 11 St. Mary-Corwin Medical Center joins Centura ... observe Heart Month throughout the month of February. ... consumer promotions to provide southern Colorado communities with ... the leading cause of death among Coloradans.Centura has ...
... of Registered Nurses Down from 2005 ProjectionsHARRISBURG, Pa., Feb. ... is shrinking, in part, because of the efforts of ... & Industry acting Secretary Sandi Vito announced today. The ... " The Registered Nurse Workforce in Pennsylvania " and ...
... following was released today by AARP Pennsylvania: WHO: ... Senator Arlene Specter. WHAT: Participants will express their ... families, businesses, and communities. And, they will hear from ... America,s health care problems under a new Administration and ...
... identified a new biological marker present in the urine ... cancer is progressing and spreading. , In experiments reported ... Nature, the scientists identified 10 metabolites that ... Their studies showed that one of these chemicals, sarcosine, ...
... say they feel unprepared for long-term care and do ... prepare for their futures, according to a survey released ... conducted by StrategyOne on behalf of AHIP, found that ... and 1980 feel somewhat or entirely unprepared for long-term ...
Cached Medicine News:Health News:Promise of Cash Prompts Smokers to Quit 2Health News:Promise of Cash Prompts Smokers to Quit 3Health News:St. Mary-Corwin Medical Center and Centura Health Celebrate Heart Month 2Health News:St. Mary-Corwin Medical Center and Centura Health Celebrate Heart Month 3Health News:Work of PA Center for Health Careers Eases Pennsylvania's Nursing Shortage 2Health News:Survey of metabolites finds new prostate cancer marker 2Health News:Survey of metabolites finds new prostate cancer marker 3Health News:Generation-X Feels Unprepared for Long-Term Care Costs and the Future, Survey Finds 2Health News:Generation-X Feels Unprepared for Long-Term Care Costs and the Future, Survey Finds 3
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
Medicine Products: